Poukalov Konstantin 4
4 · Lyra Therapeutics, Inc. · Filed May 1, 2020
Insider Transaction Report
Form 4
Poukalov Konstantin
Director
Transactions
- Award
Stock Option
2020-04-30+14,500→ 14,500 totalExercise: $16.00Exp: 2030-04-29→ Common Stock (14,500 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable in 36 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following April 30, 2020.